Thus, long-term Alli users may benefit from supplementation to prevent vitamin A, D, E and K deficiencies, as well as maintain healthy levels of essential fatty acids
In a single piece, he concisely captures: the state of the field the most important clinical trials where the pipeline is headed These Clinical trials are raising the bar and expanding future treatment options: Retatrutide ~24% weight loss (triple agonist) MariTide 1216% weight loss (GLP-1 + GIP antagonist) CagriSema up to 20% weight loss + ~2% HbA1c drop Orforglipron oral GLP-1, HbA1c 1.5%, weight 7.6% IcoSema weekly semaglutide + once-weekly insulin Even more exciting
Chi EY, Krishnan S, Randolph TW, Carpenter JF
In rodents, TNF- and interleukin-1 (IL-1) both act directly on pituitary prolactinocytes to stimulate prolactin release, a process that differs from the indirect mechanism regulated by hypothalamic dopamine (69)
This is another example where it can be hard to separate the placebo effect
Be aware that GLP-1s may affect how your bipolar medications work and worsen side effects of the meds youre currently taking, like severe constipation